title: Significance of secondary ultrasonographic endometrial thickening in postmenopausal tamoxifen-treated women.
authors.forename: Dirk
authors.initials: D
authors.lastname: Timmerman
authors.forename: Patrick
authors.initials: P
authors.lastname: Neven
authors.forename: Jan
authors.initials: J
authors.lastname: Deprest
authors.forename: Maja L
authors.initials: ML
authors.lastname: Konstantinović
authors.forename: Ignace
authors.initials: I
authors.lastname: Vergote
mesh_terms: D001943:Breast Neoplasms / Q000188:drug therapy; D016889:Endometrial Neoplasms / Q000139:chemically induced / Q000000981:diagnostic imaging* / Q000473:pathology; D004965:Estrogen Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015907:Hysteroscopy; D017698:Postmenopause; D013629:Tamoxifen / Q000009:adverse effects* / Q000627:therapeutic use; D014463:Ultrasonography
chemical_list: D004965:Estrogen Antagonists; D013629:Tamoxifen